RVMD
NASD Revolution Medicines, Inc.$205.89 ↑ +0.00 (+0.00%) Trading Up from the previous close of $205.89, $4.99 below the day’s high of $210.88
- YTD change
- +158.49%
- vs 20-day SMA
- +1.96%
- vs 200-day SMA
- +42.33%
Price ranges
Price & Performance
+106.77 (+107.72%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 8.2% away from all-time highs of $224.31
- RVMD is up 158% since the beginning of the year
- RVMD is up 349% over the past 12 months
- RVMD is down 2% over the past 1 month
- 5% of all RVMD investors are betting against RVMD
RVMD reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +350.5%.
- Previous minute
- +$2.77
- Last hour
- +$1.75
- Last 5 days
- +7.94%
- vs 8-day SMA
- +3.42%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
